EUCTR2004-002935-23-IT进行中（未招募）不适用
Phase II study of PS341 VELCADE in myelodysplastic syndromes MDS.
G.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL ADULTO0 个研究点目标入组 28 人开始时间: 2007年3月12日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
终止
2 期
Velcade in Myelodysplastic Syndrome - Pilot StudyMDSNCT00440076Gruppo Italiano Malattie EMatologiche dell'Adulto28
进行中（未招募）
1 期
Darbepoetin alfa in Anaemic Subjects With Low Risk Myelodysplastic Syndromes - Companion Studyow or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)MedDRA version: 16.0Level: HLTClassification code 10028536Term: Myelodysplastic syndromesSystem Organ Class: 100000004851EUCTR2013-000727-13-BEAmgen Inc
撤回
2 期
A Study of Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic SyndromesMyelodysplastic Syndromes (MDS)NCT04985656Takeda
招募中
3 期
Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018NL-OMON55026German Pediatric Oncology Group (GPOH) gGmbH10
进行中（未招募）
1 期
Clinical Trial for the Treatment of Myeloid Leukemia in Children with Down SyndromeEUCTR2018-002988-25-DEGesellschaft für Pädiatrische Onkologie & Hämatologie (GPOH gGmbH)150